Detalhe da pesquisa
1.
Clinical burden of invasive Escherichia coli disease among older adult patients treated in hospitals in the United States.
BMC Infect Dis
; 23(1): 550, 2023 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37608247
2.
Development and performance characteristics of novel code-based algorithms to identify invasive Escherichia coli disease.
Pharmacoepidemiol Drug Saf
; 31(9): 983-991, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35753071
3.
Budget impact analysis of first-line treatment with pazopanib for advanced renal cell carcinoma in Spain.
BMC Cancer
; 13: 399, 2013 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-24004638
4.
Enhancement and external validation of algorithms using diagnosis codes to identify invasive Escherichia coli disease.
Curr Med Res Opin
; 39(10): 1303-1312, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37608706
5.
Economic burden of invasive Escherichia coli disease among older adult patients treated in hospitals in the United States.
J Manag Care Spec Pharm
; 29(8): 873-883, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37523312
6.
Targeted Literature Review of the Burden of Respiratory Syncytial Infection among High-Risk and Elderly Patients in Asia Pacific Region.
Infect Dis Ther
; 12(3): 807-828, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36869266
7.
Targeted literature review of the burden of extraintestinal pathogenic Escherichia Coli among elderly patients in Asia Pacific regions.
J Med Econ
; 26(1): 168-178, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36647596
8.
Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium.
Vaccines (Basel)
; 11(5)2023 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37243094
9.
Reply to Standaert, B. Comment on "Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium".
Vaccines (Basel)
; 11(11)2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38006005
10.
Cost-effectiveness of ranibizumab compared with pegaptanib in neovascular age-related macular degeneration.
Graefes Arch Clin Exp Ophthalmol
; 248(4): 467-76, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19669678
11.
Cost-effectiveness of ranibizumab compared with photodynamic treatment of neovascular age-related macular degeneration.
Clin Ther
; 30(12): 2436-51, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19167602
12.
Safety and treatment patterns of angiogenesis inhibitors in patients with advanced renal cell carcinoma in Spain.
Expert Opin Drug Saf
; 12(4): 455-63, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23510293
13.
Ranibizumab for neovascular age-related macular degeneration.
Am J Health Syst Pharm
; 65(19): 1805-14, 2008 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18796421